FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106479 [Registered on: 18/03/2026] Trial Registered Prospectively
Last Modified On: 18/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparision between Dexamethasone and Clonidine as an Adjuvant to 0.5% Ropivacaine in Ultrasound Guided Pericapsular Nerve Group Block on Peri-operative Analgesia Among Patients Undergoing Total Hip Replacement Surgery at a Tertiary Care Hospital 
Scientific Title of Study   Comparision between Dexamethasone and Clonidine as an Adjuvant to zero point 5 percent Ropivacaine in Ultrasound Guided Pericapsular Nerve Group Block on Peri-operative Analgesia Among Patients Undergoing Total Hip Replacement Surgery at a Tertiary Care Hospital 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PRATEEKSHA S 
Designation  JUNIOR RESIDENT 
Affiliation  ALL INDIA INSTITUTE OF MEDICAL SCIENCES-VIJAYPUR,JAMMU 
Address  Aiims, Jammu
Department of Anaesthesiology, Aiims, Jammu and Kashmir, 184120
Jammu
JAMMU & KASHMIR
184120
India 
Phone  9483742625  
Fax    
Email  prateeksha.srinivas@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr SHRUTI SHARMA 
Designation  Additional Professor 
Affiliation  All India Institute of Medicals Sciences, Jammu 
Address  Department of Anaesthesiology, Aiims,Jammu and Kashmir, 184120
Department of Anaesthesiology, Aiims,Jammu and Kashmir, 184120
Jammu
JAMMU & KASHMIR
184120
India 
Phone  9419163183  
Fax    
Email  shruti.sharma@aiimsjammu.edu.in  
 
Details of Contact Person
Public Query
 
Name  PRATEEKSHA S 
Designation  Post Graduate Student 
Affiliation  All India Institute of Medical Sciences, Jammu 
Address  Department of Anaesthesiology, Aiims,Jammu and Kashmir, 184120
Department of Anaesthesiology, Aiims,Jammu and Kashmir, 184120
Jammu
JAMMU & KASHMIR
184120
India 
Phone  9483742625  
Fax    
Email  prateeksha.srinivas@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical sciences,Vijaypur,Jammu and Kashmir, India , 184120 
 
Primary Sponsor  
Name  All India Institute of Medical Sciences Jammu 
Address  Department of Anaesthesiology, Aiims,Jammu and Kashmir, 184120 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prateeksha S  All India Institute of Medical Sciences  Department of Anesthesiology, AIIMS, Jammu and Kashmir, 184120
Jammu
JAMMU & KASHMIR 
9483742625

prateeksha.srinivas@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute ethics committee AIIMS Jammu  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M169||Osteoarthritis of hip, unspecified, (2) ICD-10 Condition: M169||Osteoarthritis of hip, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  USG-guided PENG block with 20 ml of 0.5% Ropivacaine + Clonidine  USG-guided PENG block with 20 ml of 0.5% Ropivacaine + Clonidine.Block is performed supine using a 2–5 MHz curvilinear probe. The drug is injected into the plane between the psoas tendon and pubic ramus in 5-ml increments.We will assess pain levels using the Numeric Rating Scale (NRS) at rest and with 15° leg elevation in the PACU, as well as at 4, 8, 12, 18 and 24 hours after the surgery  
Intervention  USG-guided PENG block with 20 ml of 0.5% Ropivacaine + Dexamethasone.  USG-guided PENG block with 20 ml of 0.5% Ropivacaine + Dexamethasone.Block is performed supine using a 2–5 MHz curvilinear probe. The drug is injected into the plane between the psoas tendon and pubic ramus in 5-ml increments.We will assess pain levels using the Numeric Rating Scale (NRS) at rest and with 15° leg elevation in the PACU, as well as at 4, 8, 12, 18 and 24 hours after the surgery. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Subjects of any gender
Subjects aged between 18 to 70 years
Subjects with American Society of Anaesthesiologists status one and two who are
planned for hip surgeries. 
 
ExclusionCriteria 
Details  patient refusal
pregnant women and pediatric population
use of chronic opioids
a history of preexisting neuropathies, seizures, previous neurological deficits
those with severe chronic obstructive pulmonary disease
coagulopathy
body mass index more than or equal to 35kg msquare
history of allergy
contradiction to any drugs involved in this study
a history of other chronic pain diseases
skin rupture and infection at the puncture site

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
To compare the time required for first rescue analgesia between Dexamethasone and Clonidine as adjuvants to 0.5% Ropivacaine in ultrasound-guided Pericapsular Nerve Group (PENG) block among patients undergoing total hip replacement surgery.   4hours, 8hours, 12 hours, 18 hours, 24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
1) To compare the Ease Of Spinal Positioning (EOSP) between both adjuvants after PENG block, for spinal anaesthesia.
2)To determine Numerical Rating Scale pain Scores at rest & at 15° leg elevation in both the groups undergoing the respective blocks at first 4,8,12,18,24 hours in the post operative period.
3) To determine the total dose of rescue analgesic requirement in the first 24 hours after surgery in both patient groups. 
4 hours, 8 hours,12 hours,18 hours,24 hours in the post operative period.
 
 
Target Sample Size   Total Sample Size="54"
Sample Size from India="54" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is a prospective randomized controlled trial designed to compare the efficacy of dexamethasone versus clonidine as adjuvants to point five per cent ropivacaine in ultrasound guided Pericapsular Nerve Group block for perioperative analgesia in patients undergoing total hip replacement surgery.

A total of 52 patients belonging to ASA class 1 and 2 and aged between 18 and 70 years will be included. Participants will be randomly allocated into two groups using computer generated block randomisation.

Group A will receive ropivacaine with dexamethasone
Group B will receive ropivacaine with clonidine

The primary outcome measure is the time to first rescue analgesia.

Secondary outcome measures include ease of spinal positioning postoperative pain scores using a numeric rating scale at rest and at 15 degree leg elevation at multiple time intervals up to 24 hours and total analgesic consumption in the first 24 hours.

All patients will receive standardized spinal anesthesia and postoperative analgesia with paracetamol and fentanyl as rescue analgesic when required.

The study will be conducted over a period of 18 months at AIIMS Jammu. Statistical analysis will be performed using appropriate tests as per objective

The aim of the study is to identify the better adjuvant that prolongs duration of analgesia reduces opioid requirement and improves perioperative pain management in patients undergoing hip surgery.

 
Close